Development Level

Tbio 5 | 10,625
Tchem 1 | 1,890
Tclin 1 | 602

IMPC Term

embryonic lethality prior to t... 2 | 187
preweaning lethality, complete... 2 | 633
abnormal body wall morphology 1 | 7
abnormal embryo size 1 | 112
abnormal motor learning 1 | 4
abnormal retinal vasculature m... 1 | 15
cataract 1 | 26
cleft palate 1 | 6
enlarged heart 1 | 111
immune system phenotype 1 | 17
increased startle reflex 1 | 38

Disease

group 3 medulloblastoma 4 | 2,254
Achondroplasia 3 | 20
Breast cancer 3 | 3,094
Cancer 3 | 2,346
Cleft Lip 3 | 91
Cleft palate 3 | 125
LADD syndrome 3 | 9
invasive ductal carcinoma 3 | 2,950
malignant mesothelioma 3 | 3,162
medulloblastoma, large-cell 3 | 6,234
oligodendroglioma 3 | 2,849
osteosarcoma 3 | 7,933
ovarian cancer 3 | 8,484
pituitary cancer 3 | 1,972
psoriasis 3 | 6,685
Craniosynostosis 2 | 47
Down syndrome 2 | 548
Kallmann Syndrome 2 | 33
Klinefelter's syndrome 2 | 59
Parkinson's disease 2 | 364
Synostosis 2 | 18
atypical teratoid/rhabdoid tumor 2 | 1,095
breast carcinoma 2 | 1,614
colon cancer 2 | 1,475
ependymoma 2 | 2,514
glioblastoma 2 | 5,572
interstitial cystitis 2 | 2,299
lung cancer 2 | 4,466
non-small cell lung cancer 2 | 2,798
pediatric high grade glioma 2 | 2,712
pilocytic astrocytoma 2 | 3,086
22q11 Deletion Syndrome 1 | 7
Acanthosis nigricans 1 | 14
Acrocephalosyndactylia 1 | 15
Adenocarcinoma 1 | 115
Alobar Holoprosencephaly 1 | 14
Bladder Neoplasm 1 | 109
Brachydactyly 1 | 52
CHARGE syndrome 1 | 23
Carcinoma, Transitional Cell 1 | 31
Cardiovascular Abnormalities 1 | 7
Cervix carcinoma 1 | 6
Colon Carcinoma 1 | 25
Colorectal Neoplasms 1 | 217
Congenital absence of kidneys syndrome 1 | 5
Craniofacial Abnormalities 1 | 147
DOID:0050532 1 | 2
DiGeorge syndrome 1 | 46
Diaphragmatic Hernia 1 | 40
Duane Retraction Syndrome 1 | 9
Giant Cell Glioblastoma 1 | 12
Hamman-Rich syndrome 1 | 35
Heart disease 1 | 279
Holoprosencephaly 1 | 52
Hypochondroplasia 1 | 11
Hypogonadism 1 | 70
Hypospadias 1 | 65
Hypotension 1 | 53
Kabuki syndrome 1 | 27
Keratosis 1 | 34
Leukemia 1 | 88
Lobar Holoprosencephaly 1 | 14
Lung Neoplasms 1 | 171
Malignant neoplasm of urinary bladder 1 | 16
Mesothelioma 1 | 40
Multiple synostoses syndrome 1 | 8
NEVUS, EPIDERMAL (disorder) 1 | 4
Opitz-GBBB syndrome 1 | 19
Osteoarthritis 1 | 96
PARKINSON DISEASE, LATE-ONSET 1 | 18
Polycystic Ovary Syndrome 1 | 332
Proximal symphalangism 1 | 6
Pulmonary Fibrosis 1 | 66
Renal Cell Carcinoma 1 | 199
Renal agenesis 1 | 25
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR 1 | 14
Saethre-Chotzen syndrome 1 | 9
Sarcoma of soft tissue 1 | 11
Seborrheic keratosis 1 | 6
Semilobar Holoprosencephaly 1 | 14
Seminoma 1 | 15
Skin cancer 1 | 37
Testicular Germ Cell Tumor 1 | 22
Thanatophoric dysplasia 1 | 5
Upper respiratory tract disease 1 | 7
Urinary bladder cancer 1 | 31
Urinary system cancer 1 | 2
Uterine Cervical Neoplasm 1 | 21
Vascular disease 1 | 281
Velocardiofacial syndrome 1 | 45
Weight Gain 1 | 87
Wolf-Hirschhorn syndrome 1 | 32
active ulcerative colitis 1 | 477
cystic fibrosis 1 | 1,665
gliosarcoma 1 | 19
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
non-invasive bladder papillary urothelial neoplasm 1 | 4
non-small cell lung carcinoma 1 | 413
tuberculosis 1 | 1,557
type II diabetes mellitus and post-ischemic heart failure 1 | 89

Tissue

Blood and immune system 7 | 17,995
Cardiovascular System 7 | 17,958
Digestive Tract 7 | 18,473
Endocrine System 7 | 18,512
Female tissues 7 | 18,647
Liver and Pancreas 7 | 18,136
Male tissues 7 | 17,969
Nervous System 7 | 18,561
Respiratory system 7 | 17,484
Skin and soft tissues 7 | 18,115
Urinary Tract 7 | 18,444

Target Family

Non-IDG 6 | 11,971
Kinase 1 | 634

Reactome Pathway

FGFR3b ligand binding and acti... 7 | 7
Signal Transduction 2,516 | 2,516
Immune System 2,184 | 2,184
Metabolism 2,132 | 2,132
Gene Expression 1,755 | 1,755
Metabolism of proteins 1,545 | 1,545
Innate Immune System 1,376 | 1,376
Signaling by GPCR 1,330 | 1,330
Developmental Biology 1,029 | 1,029
GPCR downstream signaling 1,015 | 1,015
Post-translational protein mod... 1,005 | 1,005
Adaptive Immune System 939 | 939
Disease 856 | 856
Generic Transcription Pathway 852 | 852
Cytokine Signaling in Immune s... 804 | 804
Metabolism of lipids and lipop... 797 | 797
Vesicle-mediated transport 705 | 705
Hemostasis 669 | 669
Transmembrane transport of sma... 669 | 669
Membrane Trafficking 608 | 608
Cell Cycle 573 | 573
Axon guidance 542 | 542
Neutrophil degranulation 542 | 542
Signaling by Interleukins 501 | 501
Cell Cycle, Mitotic 471 | 471
Signalling by NGF 468 | 468
GPCR ligand binding 456 | 456
Gastrin-CREB signalling pathwa... 436 | 436
Class I MHC mediated antigen p... 431 | 431
Olfactory Signaling Pathway 430 | 430
Fc epsilon receptor (FCERI) si... 424 | 424
Cellular responses to stress 416 | 416
DAP12 interactions 410 | 410
Infectious disease 392 | 392
NGF signalling via TRKA from t... 379 | 379
Signaling by Rho GTPases 378 | 378
Signaling by PDGF 368 | 368
Diseases of signal transductio... 360 | 360
Signaling by EGFR 356 | 356
Transcriptional Regulation by ... 356 | 356
Metabolism of amino acids and ... 354 | 354
DAP12 signaling 347 | 347
Downstream signal transduction 344 | 344
Neuronal System 343 | 343
Organelle biogenesis and maint... 334 | 334
Signaling by VEGF 330 | 330
Signaling by SCF-KIT 328 | 328
Class A/1 (Rhodopsin-like rece... 322 | 322
VEGFA-VEGFR2 Pathway 322 | 322
FCERI mediated MAPK activation 317 | 317
Signaling by Insulin receptor 313 | 313
Antigen processing: Ubiquitina... 302 | 302
Extracellular matrix organizat... 292 | 292
Signaling by Type 1 Insulin-li... 291 | 291
Signaling by Wnt 291 | 291
IGF1R signaling cascade 290 | 290
IRS-related events triggered b... 290 | 290
Insulin receptor signalling ca... 289 | 289
Metabolism of carbohydrates 288 | 288
DNA Repair 286 | 286
IRS-mediated signalling 286 | 286
MAPK family signaling cascades 284 | 284
Signaling by the B Cell Recept... 283 | 283
Asparagine N-linked glycosylat... 282 | 282
SLC-mediated transmembrane tra... 280 | 280
Deubiquitination 278 | 278
Interferon Signaling 275 | 275
Platelet activation, signaling... 274 | 274
NCAM signaling for neurite out... 269 | 269
M Phase 267 | 267
Interleukin-3, 5 and GM-CSF si... 263 | 263
RET signaling 262 | 262
Signalling to ERKs 255 | 255
Interleukin-2 signaling 254 | 254
Immunoregulatory interactions ... 252 | 252
VEGFR2 mediated cell prolifera... 250 | 250
RHO GTPase Effectors 249 | 249
Signalling to RAS 248 | 248
Interleukin receptor SHC signa... 247 | 247
G alpha (i) signalling events 245 | 245
Signaling by Leptin 245 | 245
Fatty acid, triacylglycerol, a... 244 | 244
Prolonged ERK activation event... 244 | 244
MAPK1/MAPK3 signaling 243 | 243
Frs2-mediated activation 242 | 242
HIV Infection 242 | 242
ARMS-mediated activation 241 | 241
Signalling to p38 via RIT and ... 241 | 241
Chromatin modifying enzymes 237 | 237
Chromatin organization 237 | 237
GRB2 events in EGFR signaling 237 | 237
RAF/MAP kinase cascade 237 | 237
SHC1 events in EGFR signaling 237 | 237
SOS-mediated signalling 237 | 237
Processing of Capped Intron-Co... 235 | 235
Biological oxidations 215 | 215
Keratinization 213 | 213
Transmission across Chemical S... 210 | 210
rRNA processing 209 | 209
Ion channel transport 204 | 204
Ub-specific processing proteas... 203 | 203

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Fibroblast growth factor 18 FGF18 Tbio Non-IDG -1.83412 76.6 133
Fibroblast growth factor receptor 3 FGFR3 Tclin Kinase -2.97148 995.1 350
Fibroblast growth factor 20 FGF20 Tbio Non-IDG -1.66650 53.1 104
Fibroblast growth factor 17 FGF17 Tbio Non-IDG -1.54736 35.2 131
Fibroblast growth factor 8 FGF8 Tbio Non-IDG -2.70893 513.2 251
Fibroblast growth factor 9 FGF9 Tbio Non-IDG -2.24751 201.5 201
Fibroblast growth factor 1 FGF1 Tchem Non-IDG -3.18823 1583.2 445